G207 with radiation for children with high-grade glioma
Original title: Phase 2 Trial of G207 + 5 Gy Radiation for Children With High-Grade Gliomas
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is a mid stage study in people, and the results are not in yet.
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study is testing a treatment called G207, given with radiation, in children whose high-grade glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary has come back or is growing.
Who this trial is for. This trial is for children with a high-grade glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary that has come back or is getting worse. It tests G207 given together with radiation therapy.
Where it stands. This trial has not reported results. It is looking at how safe G207 with radiation is, and what effects it has. Those answers are not in yet.
What this means, and what it doesn't
What it could mean: If your child has a high-grade glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary that came back or is growing, this is one study to know about. You could ask your care team if it might fit. They can help you look at the trial and talk through the risks.
What it doesn't mean: This does not mean G207 with radiation works. A trial is a test, not a proven treatment. Joining a trial is not a guarantee that it will help. It is not a promise of a cure. We also cannot say who will be able to join. That is decided by the trial team.
Source: ClinicalTrials.gov, July 29, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.